CorMedix announces preliminary, unaudited financial results for Q4 and FY 2025, including net revenue of approximately $127 million and $310 million, for Q4 2025 and FY 2025, respectively, FY 2025 Pro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback